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Abstract
Background: Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a genodermatosis caused by more than 500
different mutations in the COL7A1 gene and characterized by blistering of the skin following a minimal friction or
mechanical trauma.
The identification of a cluster of RDEB pedigrees carrying the c.6527insC mutation in a specific area raises the question
of the origin of this mutation from a common ancestor or as a result of a hotspot mutation. The aim of this study was
to investigate the origin of the c.6527insC mutation.
Methods: Haplotypes were constructed by genotyping nine single nucleotides polymorphisms (SNPs) throughout
the COL7A1 gene. Haplotypes were determined in RDEB patients and control samples, both of Spanish origin.
Results: Sixteen different haplotypes were identified in our study. A single haplotype cosegregated with the
c.6527insC mutation.
Conclusion: Haplotype analysis showed that all alleles carrying the c.6527insC mutation shared the same haplotype
cosegregating with this mutation (CCGCTCAAA_6527insC), thus suggesting the presence of a common ancestor.
Background
Dystrophic Epidermolysis Bullosa (DEB) is a rare disease,
characterized by trauma induced-blistering and scarring
[1]. This genodermatosis is a rare autosomal dominant
(DDEB [MIM#131750, #131800]) or recessive (RDEB
[MIM#226600]) disorder caused by mutations in COL7A1
gene [MIM*120120], encoding type VII collagen (protein
component of anchoring fibrils) [2]. COL7A1 gene is an
unusually complex gene with 118 exons. It has the second
largest number of exons of all genes described to date [3].
So far, more than 500 mutations have been described in
the COL7A1 gene http://www.hgmd.cf.ac.uk [4]. Although
COL7A1 genetic database indicates that most of the
DEB mutations are family specific, with few recurrent
mutations, in the Spanish cohort, a high recurrence of
the c.6527insC pathogenic mutation has recently been
reported by our group [5]. Accounting for 46.3% of alleles
this is a level of recurrence for a single genetic defect
hardly ever found for the COL7A1 gene [5,6]. The
c.6527insC mutation creates a premature codon termina-
tion (PTC), leading to nonsense mediated decay (NMD)
that manifests as a complete absence of collagen protein
(Fig. 1). This insertion mutation was detected mainly in
families native of the southwest of the Iberian Peninsula
(Fig. 2). The overrepresentation of a single mutation and
the geographic clustering of the c.6527insC pedigrees indi-
cate at least one founder effect or a mutational hotspot.
We investigated the putative founder effect of the
c.6527insC mutation through the construction of SNP
haplotypes throughout the COL7A1 gene. A rare single
haplotype in the Spanish population was present in all
patients and relatives who carried the c.6527insC muta-
tion, supporting the hypothesis that all chromosomes car-
rying the c.6527insC mutation arise from a single founder
effect. * Correspondence: marcela.delrio@ciemat.es
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Subjects
A total of 49 DEB patients were included in this study.
Patient written informed consent was obtained in agree-
ment with the collaborative centers where biopsies and
blood/DNA samples were obtained. The Ethics Commit-
tee of Fundación Jimenez Díaz (Madrid, Spain) evalu-
ated and approved this research work, stating that the
project adheres to the Helsinki Guidelines and further
reviews (Edinburgh, 2000; http://www.wma.net).
Eleven RDEB patients carried the c.6527insC mutation
in both alleles. Sixteen RDEB patients were heterozy-
gote, exhibited the c.6527insC mutation on one allele
and contained different mutations on the other allele.
Twenty two DEB patients carried other mutations of the
COL7A1 gene (Additional file 1, Table S1). In addition,
93 non-affected individuals from the general population
of Spain were incorporated to this study as a reference
group. Informed consent was obtained from all subjects
included in the study. Putative geographic origin of ped-
igrees was empirically established based on proof that
individuals carrying this mutation stem from ancestors
w h oh a v el i v e di nt h es a m eg e o g r a p h i ca r e af o ra tl e a s t
3 generations.
SNPs selection and haplotyping assay
We used the HapMap data http://www.hapmap.org to
select informative SNPs from the COL7A1 gene. Using
the Haploview program, two blocks of linkage disequili-
brium (LD) are located throughout the COL7A1 gene
(Fig. 3). Two SNPs (rs2228561 and rs1264194) from
block 1 and five SNPs (rs9881877, rs9871180, rs9814951,
rs9878950 and rs2532848) from block 2 were analyzed
to determine common haplotypes according to the
Figure 1 Molecular and microscopic characterization of RDEB patients that are homozygotes for c.6527insC in exon 80.( A )
Identification of the c.6527insC mutation by direct DNA sequence analysis. The chromatogram shows the pattern of 7 C peaks typically found in
these patients (left) when compared with healthy controls (right). (B) Indirect immunofluorescent staining with LH7.2 monoclonal antibody (NC-1
domain of type VII collagen). The control section shows a continuous staining along the intact dermal-epidermal junction (right), while the
section from the patient is negative to the staining and show a dermal-epidermal cleavage (*).
Figure 2 Geographic location of alleles carrying the c.6527insC
mutation in RDEB patients (red circles). Circle size is proportional
to the number of CCGCTCAAA_6527insC alleles. The mutation
follows a south-north spatial gradient in the Iberian Peninsula, from
Andalusia to Northern Spain. Note that only three alleles that carry
the c.6527insC mutation occur in the rest of Europe (blue circles,
France, Germany and Portugal).
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novel polymorphisms, NM-000094.3:c.25215C >T (intron
75) and NM-000094.3:c.11639C >T (intron 19) recog-
nized in the Spanish population.
Haplotypes for chromosomes harboring the c.6527insC
mutation and other mutations were determined by geno-
typing SNPs for DEB patients and their parents (Fig. 4).
The genotyping of SNPs was performed with Snapshot
assay kits (Applied Biosystems Inc.). Amplicons were
purified by Exo-SAP treatment (ExoSAP-IT, USB).
Three μl aliquots of the purified amplification products
were added to a 5 μl Snapshot Multiplex Ready reaction
mixture containing 0.4 pmol of each Snapshot oligonu-
cleotide primers (Additional file 1, Table S2). Primer
extension reactions were carried out over 25 cycles of
96°C for 10 sec, 50°C for 5 sec, and 60°C for 30 sec.
Reaction products were treated with 1 U of SAP at 37°C
for 1 h and 72°C for 15 min to dephosphorylate unin-
corporated fluorescent ddNTPs. The Snapshot reactions
were resolved on an ABI Prism 3730 (Applied Biosys-
tems). Results were analyzed using Peak Scanner™ Soft-
ware v1.0 (Applied Biosystems).
Statistical analysis
We evaluated the Hardy-Weinberg Equilibrium (HWE)
distributions, in a control sample from the general
population of Spain, for the SNPs involved in our study.
Results
We identified 5 novel SNPs in the region corresponding
to COL7A1 gene, NM-000094.3:c.11639C>T, 24558C>T,
25215C>T, 29056C>T, 31427C>A. The distribution of all
SNPs in the control Spanish population did not deviate
from HWE (?2-test; p > 0.05) (Additional file 1, Table
S3). The NM-000094.3:c.11639C>T and 25215C>T were
considered for the construction of haplotypes.
The existence of complete two-generation pedigrees in
all our patients allowed the construction of different hap-
lotypes formed by nine SNPs. Considering the two blocks
of linkage LD located throughout the COL7A1 gene, we
determined twelve haplotypes in DEB patients (from H1
haplotype to H7 haplotype, H9, H12, H14, H15 and H16
haplotypes) and thirteen haplotypes in the Spanish popu-
lation (from H1 to H13). The overall distribution of the
estimated haplotypes was significantly different between
healthy controls and patients (see Table 1 and Table 2).
The total number of the alleles (n = 38) that carry the
c.6527insC mutation cosegregated exclusively with H5
haplotype (CCGCTCAAA), namely all alleles that carry
the c.6527insC mutation were CCGCTCAAA_6527insC.
On the other hand, the frequency of H5 haplotype in the
Spanish population was 5.81%. Consequently, the
c.6527insC mutation in the Spanish cluster is a result of a
single mutational event, and the affected pedigrees must
descend from one genetic founder who exhibited the H5
Figure 3 Haplotype structure of the COL7A1 gene locus in Europeans. (A) Structure of the COL7A1 gene with positions of SNPs by the Hap
Map project. Haploview-generated linkage disequilibrium (LD) patterns of the COL7A1 gene and predicted block structure in Caucasian control
subjects. Rate (D’) of LD is represented by different colors (highest rate of LD in red, lower LD in purple, and white for no LD). (B) Potential
haplotypes in the European population for six selected SNPs that have been genotyped in our study.
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Page 3 of 7Figure 4 Some pedigrees of Spanish cases of DEB are shown as an example. The existence of complete two-generation pedigrees in DEB
patients allowed construction of different haplotypes throughout the COL7A1 gene. The haplotypes are boxed. Symbols are encoded as follows:
black, DEB patients; white and black, carrying recessive mutations.
Table 1 The total number of haplotypes described in the Spanish population
Block 2 Block 1
Haplotypes rs2228561 11639
C>T
rs1264194 rs9881877 25215C>T rs9871180 rs9814951 rs9878950 rs2532848 Haplotype
frequency
%
H1 C C G C C C A A C 33.7
H2 C C A C C C A A C 17.44
H3 C C A C C C G G C 10.46
H4 C C G C C C A G C 5.81
H5 C C G C T C A A A 5.81
H6 T C G C C C A A C 4.65
H7 C C G T C C A A C 4.65
H8 C C G C C C G G C 4.65
H9 C C G C C C A A A 3.49
H10 C C G C T C A A C 3.49
H11 C - A C C C A G C 3.49
H12 C C G T C T G G C 1.16
H13 C - A C T C A A C 1.16
H14 C T G C T C A A A 0
H15 C T G C T C A G A 0
H16 C T G C C C A A C 0
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CCGCTCAAA_6527insC allele, 26 stemmed from ances-
tors who had been living in the southern half of the Iber-
ian Peninsula for at least 3 generations. The other lineage
bearing the CCGCTCAAA_6527insC allele comes from
ancestors who had been living in Northern Spain for over
3 generations. In addition, we analyzed a Portuguese pedi-
gree carrier of the CCGCTCAAA_6527insC allele. These
results reveal that the c.6527insC mutation is not the
result of separate mutations occurring independently in
different individuals, but is the result of a one-time muta-
tion occurring in a common ancestor of all the families.
Furthermore, we also found a pedigree where the chromo-
some carrying the mutation cosegregated with G2520V
H5 haplotype. The other forty recessive pathogenic muta-
tions cosegregate with other fifteen different haplotypes
(Table 2).
Discussion
High carrier rates are usually attributed to a founder effect
in a population and are usually evidenced by conservation
of haplotypes with directly associated markers [7].
We constructed fifteen different intragenic haplotypes
throughout the COL7A1 gene to explore the origin of the
Table 2 The total number of haplotypes described in DEB Spanish patients
Block 2 Block 1
Haplotypes Mutation COL7A1
gene
rs2228561 11639
C>T
rs1264194 rs9881877 25215C>T rs9871180 rs9814951 rs9878950 rs2532848
H1 p.Y112X (1), p.R185X
(2), p.G1318R (1),
p.G1791E (1), p.R1814C
(1), p.G2061V (1),
p.G2061V (1), p.
R2424W (1), p.G2587 D
(1),
p.R2622W(1), p.2737V
(1), c.267-3C>G (2),
c.4401+1G>A(1),
c.7420A>G (1), c.7930-
1G>C (3),
c.7930+2T>C,
c.7756insC.
CCG C C C A A C
H2 p.R525X (1), p.R1730X
(1), p.R2063W (1),
c.7104+5G>A (1),
c.5576delAA (1),
c.325insGC (2),
CCA C C C A A C
H3 p.G2434R (1), p.R2808C
(1)
CCA C C C G G C
H4 c.58del13 (1) C C G C C C A G C
H5 c.6527insC (38), p.
G2520V (1)
C C GCTCAAA
H6 p.Y1098X (2),
c.2781InsACGAC (1),
c.8304+1G>A (1)
TCG C C C A A C
H7 p.G2366 D (1), p.G2114
D (1)
CCG T C C A A C
H8 - C C G C C C G G C
H9 p.G1332 D (1), c.R525X
(1), ND(1)
CCG C C C A A A
H 1 0 - C C GCTCAAC
H11 - C - A C C C A G C
H12 p.G2722V, c.8717delC
(1), ND (1).
CCG T C T G G C
H 1 3 - C T ACTCAAC
H14 c.5131nsCTCAC (2),
c.3277-1G>C (1)
CTG C T C A A A
H15 ND (2) C T G C T C A G A
H16 c.7929+2T>C (1) C T G C C C A A C
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tions described in our DEB patients. All alleles carrying
the c.6527insC mutation were CCGCTCAAA_6527insC,
indicating a common origin. This hypothesis is supported
by the diversity of haplotypes throughout the COL7A1
gene. Moreover, H5 haplotype is rare in the control popu-
lation (5.81%).
The c.6527insC mutation is found at a high prevalence
among patients from the southern half of the Iberian
Peninsula. This mutation has previously been found in
one patient in France [8] and in another in Germany [9].
However, a Spanish predecessor of those patients cannot
be excluded, taking into account the large Spanish emi-
gration to France that occurred after the Spanish civil
war (1936-1939) and to Germany in the early 1960 s due
to economic hard-ship.
The overall distribution of the estimated haplotypes was
significantly different between patients and healthy con-
trols. The absence of recurrence in the other mutations
did not allow us to distinguish whether a single haplotype
is associated with a mutation, or conversely, if one muta-
tion is associated with general haplotypes suggesting mul-
tiple origins. The H1 and H2 haplotypes identified as
cosegregating with other mutations are common in the
background population. This finding is neither surprising
nor unexpected. In terms of elementary probability, the
probability of occurrence of a pathogenic mutation in a
chromosome harboring a relatively common haplotype in
the population is obviously high.
We found a single mutation, p.R525X, which cosegre-
gated with two different haplotypes (H2 haplotype and
H9 haplotype). Moreover this nonsense mutation has
been described previously in other DEB patient cohorts
[10]. This could indicate the presence of a mutational
hotspot in codon 525 of COL7A1 gene. Codon 525 con-
tains a CpG dinucleotide, which is the known site of
DNA modification by cytosine methylation.
Conclusion
In summary, the conservation of a single haplotype sur-
rounding the c.6527insC mutation suggested that this
allele has a single origin. The finding of a founder effect
in a highly recurrent mutation in a rare disease charac-
terized by intrafamilial mutations is essential for the
implementation of protocols for genetic diagnosis, for
genetic counselling of affected pedigrees and is funda-
mental to search for new therapies.
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